NO329667B1 - 1-fenyl-2-(pyridyl eller tienyl)-substituerte benzimidazolderivater, farmasoytiske preparater som inneholder forbindelsene og anvendelse av disse for fremstilling av legemidler benyttet for behandling av immunologiske sykdommer - Google Patents

1-fenyl-2-(pyridyl eller tienyl)-substituerte benzimidazolderivater, farmasoytiske preparater som inneholder forbindelsene og anvendelse av disse for fremstilling av legemidler benyttet for behandling av immunologiske sykdommer Download PDF

Info

Publication number
NO329667B1
NO329667B1 NO20043841A NO20043841A NO329667B1 NO 329667 B1 NO329667 B1 NO 329667B1 NO 20043841 A NO20043841 A NO 20043841A NO 20043841 A NO20043841 A NO 20043841A NO 329667 B1 NO329667 B1 NO 329667B1
Authority
NO
Norway
Prior art keywords
oxy
benzimidazol
phenyl
thienyl
acid
Prior art date
Application number
NO20043841A
Other languages
English (en)
Norwegian (no)
Other versions
NO20043841L (no
Inventor
Herbert Schneider
Wolfgang Halfbrodt
Thorsten Blume
Joachim Kuhnke
Ursula Monning
Bernd Elger
Original Assignee
Bayer Ip Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bayer Ip Gmbh filed Critical Bayer Ip Gmbh
Publication of NO20043841L publication Critical patent/NO20043841L/no
Publication of NO329667B1 publication Critical patent/NO329667B1/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing three or more hetero rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Immunology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pulmonology (AREA)
  • Transplantation (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
NO20043841A 2002-02-15 2004-09-14 1-fenyl-2-(pyridyl eller tienyl)-substituerte benzimidazolderivater, farmasoytiske preparater som inneholder forbindelsene og anvendelse av disse for fremstilling av legemidler benyttet for behandling av immunologiske sykdommer NO329667B1 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE10207844A DE10207844A1 (de) 2002-02-15 2002-02-15 1-Phenyl-2-heteroaryl-substituierte Benzimidazolderivate, deren Verwendung zur Herstellung von Arzneimitteln sowie diese Derivate enthaltende pharmazeutische Präparate
PCT/EP2003/000462 WO2003068766A1 (fr) 2002-02-15 2003-01-17 Derives de benzimidazole 1-phenyl-2-heteroaryl substitues et leur utilisation pour produire des medicaments servant a traiter des maladies immunologiques

Publications (2)

Publication Number Publication Date
NO20043841L NO20043841L (no) 2004-11-12
NO329667B1 true NO329667B1 (no) 2010-11-29

Family

ID=27674913

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20043841A NO329667B1 (no) 2002-02-15 2004-09-14 1-fenyl-2-(pyridyl eller tienyl)-substituerte benzimidazolderivater, farmasoytiske preparater som inneholder forbindelsene og anvendelse av disse for fremstilling av legemidler benyttet for behandling av immunologiske sykdommer

Country Status (30)

Country Link
EP (1) EP1474415B1 (fr)
JP (1) JP4739675B2 (fr)
KR (1) KR101027556B1 (fr)
CN (1) CN1317274C (fr)
AR (1) AR038492A1 (fr)
AT (1) ATE517881T1 (fr)
AU (1) AU2003205624B2 (fr)
BR (1) BR0307723A (fr)
CA (1) CA2475780C (fr)
CR (1) CR7442A (fr)
CY (1) CY1113230T1 (fr)
DE (1) DE10207844A1 (fr)
DK (1) DK1474415T3 (fr)
EC (1) ECSP045296A (fr)
ES (1) ES2369662T3 (fr)
IL (1) IL163431A (fr)
MX (1) MXPA04007949A (fr)
NO (1) NO329667B1 (fr)
NZ (1) NZ534660A (fr)
PE (1) PE20030941A1 (fr)
PL (1) PL216233B1 (fr)
PT (1) PT1474415E (fr)
RS (1) RS51831B (fr)
RU (1) RU2325384C2 (fr)
SI (1) SI1474415T1 (fr)
TW (1) TWI328583B (fr)
UA (1) UA81243C2 (fr)
UY (1) UY27661A1 (fr)
WO (1) WO2003068766A1 (fr)
ZA (1) ZA200407381B (fr)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2309154C9 (ru) 2002-03-27 2016-09-27 Глэксо Груп Лимитед 3-фенилсульфонил-8-пиперазин-1-ил-хинолины, обладающие аффинностью к 5-нт6 рецептору, способы их получения (варианты)
MXPA05012459A (es) * 2003-05-19 2006-02-22 Irm Llc Compuestos y composiciones inmunosupresoras.
WO2014044611A1 (fr) 2012-09-20 2014-03-27 Bayer Pharma Aktiengesellschaft 1-aryl-2-hétéroaryl benzimidazoles pour l'induction de la régénérescence neuronale

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4430502A (en) * 1982-08-13 1984-02-07 The Upjohn Company Pyridinyl substituted benzimidazoles and quinoxalines
ATE163290T1 (de) * 1991-06-24 1998-03-15 Neurosearch As Imidazol-verbindungen, verfahren zu ihrer herstellung und ihre anwendung
DE4129603A1 (de) * 1991-09-06 1993-03-11 Thomae Gmbh Dr K Kondensierte 5-gliedrige heterocyclen, verfahren zu ihrer herstellung und diese verbindungen enthaltende arzneimittel
DE4330959A1 (de) * 1993-09-09 1995-03-16 Schering Ag Neue Benzimidazolderivate, Verfahren zu ihrer Herstellung und ihre pharmazeutische Verwendung
EP0980359B1 (fr) * 1997-05-01 2004-06-23 Nissan Chemical Industries, Ltd. Derive de benzimidazole
EP1214330A1 (fr) * 1999-09-21 2002-06-19 LION Bioscience AG Derives de benzimidazole et bibliotheques combinatoires contenant ces derives
EE05515B1 (et) 2000-01-14 2012-02-15 Schering@Aktiengesellschaft 1 2 diarlbensimidasoolid mikrogliia aktivatsiooniga seotud haiguste raviks
US7115645B2 (en) * 2000-01-14 2006-10-03 Schering Aktiengesellschaft 1,2 diarylbenzimidazoles and their pharmaceutical use
DE10207843A1 (de) * 2002-02-15 2003-09-04 Schering Ag Mikrolia-Inhibitoren zur Unterbrechung von Interleukin 12 und IFN-gamma vermittelten Immunreaktionen

Also Published As

Publication number Publication date
RS51831B (sr) 2012-02-29
CA2475780A1 (fr) 2003-08-21
TW200303307A (en) 2003-09-01
JP4739675B2 (ja) 2011-08-03
RS71404A (sr) 2006-10-27
CN1633429A (zh) 2005-06-29
RU2004127678A (ru) 2005-07-10
SI1474415T1 (sl) 2011-12-30
UA81243C2 (en) 2007-12-25
PT1474415E (pt) 2011-10-13
UY27661A1 (es) 2003-09-30
WO2003068766A1 (fr) 2003-08-21
AU2003205624B2 (en) 2009-08-27
AU2003205624A1 (en) 2003-09-04
ZA200407381B (en) 2005-11-30
KR20040081795A (ko) 2004-09-22
PL216233B1 (pl) 2014-03-31
TWI328583B (en) 2010-08-11
ECSP045296A (es) 2004-10-26
CY1113230T1 (el) 2016-04-13
KR101027556B1 (ko) 2011-04-06
PL371269A1 (en) 2005-06-13
MXPA04007949A (es) 2004-11-26
IL163431A (en) 2010-11-30
EP1474415A1 (fr) 2004-11-10
DE10207844A1 (de) 2003-09-04
JP2005521686A (ja) 2005-07-21
AR038492A1 (es) 2005-01-19
BR0307723A (pt) 2005-01-25
NZ534660A (en) 2006-02-24
RU2325384C2 (ru) 2008-05-27
CR7442A (es) 2006-02-06
CN1317274C (zh) 2007-05-23
ES2369662T3 (es) 2011-12-02
CA2475780C (fr) 2011-08-02
NO20043841L (no) 2004-11-12
ATE517881T1 (de) 2011-08-15
EP1474415B1 (fr) 2011-07-27
DK1474415T3 (da) 2011-11-21
PE20030941A1 (es) 2004-01-17

Similar Documents

Publication Publication Date Title
EP2704701B1 (fr) Composés pour une inflammation et des utilisations apparentées au système immunitaire
JP2005516950A (ja) 代謝型グルタミン酸受容体−５のヘテロアリール置換イミダゾールモジュレータ
TW201026693A (en) Compounds for inflammation and immune-related uses
US6855714B2 (en) 1-alkyl-2-aryl-benzimidazole derivatives, their use for the production of pharmaceutical agents as well as pharmaceutical preparations that contain these derivatives
JP2004530731A (ja) １−アルキル−２−アリール−ベンズイミダゾール誘導体、医薬製剤の製造のためへのそれらの使用、及びそれらの誘導体を含む医薬製剤
JP2006522128A (ja) 代謝調節型グルタミン酸受容体−５のモジュレーターとしての４環イミダゾール誘導体
NO329667B1 (no) 1-fenyl-2-(pyridyl eller tienyl)-substituerte benzimidazolderivater, farmasoytiske preparater som inneholder forbindelsene og anvendelse av disse for fremstilling av legemidler benyttet for behandling av immunologiske sykdommer
AU2016232978B2 (en) Compositions for the treatment of fibrosis and fibrosis-related conditions
CA2853485A1 (fr) Composes et utilisations liees aux inflammations et au systeme immunitaire
JP4351042B2 (ja) 小グリア細胞−活性化−関連疾患、例えば炎症、アレルギー感染又は自己免疫疾患を処理するためのベンズイミダゾール誘導体類
US6962932B2 (en) 1-phenyl-2-heteroaryl-substituted benzimdazole derivatives, their use for the production of pharmaceutical agents as well as pharmaceutical preparations that contain these derivatives
US6903126B2 (en) 1-Aryl-2-N-, S- or O-substituted benzimidazole derivatives, their use for the production of pharmaceutical agents as well as pharmaceutical preparations that contain these derivatives
WO2012064808A1 (fr) Composés de tétrazolyl-tétrahydropyridine pour le traitement de troubles inflammatoires et immunitaires
HK1195734A (en) Compounds for inflammation and immune-related uses

Legal Events

Date Code Title Description
CHAD Change of the owner's name or address (par. 44 patent law, par. patentforskriften)

Owner name: BAYER INTELLECTUAL PROPERTY GMBH, DE

MM1K Lapsed by not paying the annual fees